Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCQB - Delayed Quote USD

MediPharm Labs Corp. (MEDIF)

Compare
0.0738
+0.0038
+(5.43%)
At close: 3:36:43 PM EDT
Loading Chart for MEDIF
  • Previous Close 0.0700
  • Open 0.0661
  • Bid 0.0693 x --
  • Ask 0.0745 x --
  • Day's Range 0.0661 - 0.0738
  • 52 Week Range 0.0370 - 0.0850
  • Volume 90,521
  • Avg. Volume 112,470
  • Market Cap (intraday) 30.341M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date May 15, 2025 - May 25, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

www.medipharmlabs.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MEDIF

View More

Performance Overview: MEDIF

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

MEDIF
67.73%
S&P/TSX Composite index (^GSPTSE)
2.79%

1-Year Return

MEDIF
17.14%
S&P/TSX Composite index (^GSPTSE)
14.64%

3-Year Return

MEDIF
45.33%
S&P/TSX Composite index (^GSPTSE)
15.28%

5-Year Return

MEDIF
82.92%
S&P/TSX Composite index (^GSPTSE)
93.22%

Compare To: MEDIF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MEDIF

View More

Valuation Measures

Annual
As of 4/1/2025
  • Market Cap

    28.57M

  • Enterprise Value

    19.92M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.02

  • Price/Book (mrq)

    0.91

  • Enterprise Value/Revenue

    0.73

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: MEDIF

View More

Company Insights: MEDIF

Research Reports: MEDIF

View More

People Also Watch